Hansa Biopharma AB (publ) (STO:HNSA)
Sweden · Delayed Price · Currency is SEK 26.20
+0.32 (1.24%)
Jul 23, 2025, 5:29 PM CET
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of 2.22 billion as of July 23, 2025. Its market cap has decreased by -32.42% in one year.
Market Cap
2.22B
Enterprise Value
2.77B
Revenue
196.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.20
Market Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 30.71M to 2.22B, an increase of 7,130.96%. That is a compound annual growth rate of 28.15%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 93.25B |
| Sectra AB | 69.37B |
| Getinge AB | 51.42B |
| Camurus AB | 41.42B |
| Medicover AB | 38.58B |
| Asker Healthcare Group AB | 38.47B |
| AddLife AB | 20.91B |
| Bonesupport Holding AB | 20.64B |